- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anti-atherogenic effects of fibrates in type 2 diabetes ; volume:2 ; number:5 ; day:24 ; month:9 ; year:2001 ; pages:1-3 ; date:10.2001
Trials ; 2, Heft 5 (24.9.2001), 1-3, 10.2001
- Creator
-
Barter, Philip
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/cvm-2-5-218
- URN
-
urn:nbn:de:1111-2016050215121
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Barter, Philip
- SpringerLink (Online service)
Other Objects (12)
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Effects of vitamin K2 supplementation on atherogenic status of individuals with type 2 diabetes: a randomized controlled trial
Effects of various anti-atherogenic agents and extracellular matrix on vessel wall cells
Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions
Anti-Dyslipemic Effect of Suloctidil in Rhesus Monkeys Under Atherogenic Diet
Anti‐Atherogenic Effect of Stem Cell Nanovesicles Targeting Disturbed Flow Sites
Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance
Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Effects of vitamin K2 supplementation on atherogenic status of individuals with type 2 diabetes: a randomized controlled trial
Effects of various anti-atherogenic agents and extracellular matrix on vessel wall cells
Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions
Anti-Dyslipemic Effect of Suloctidil in Rhesus Monkeys Under Atherogenic Diet
Anti‐Atherogenic Effect of Stem Cell Nanovesicles Targeting Disturbed Flow Sites
Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance
Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Effects of vitamin K2 supplementation on atherogenic status of individuals with type 2 diabetes: a randomized controlled trial
Effects of various anti-atherogenic agents and extracellular matrix on vessel wall cells
Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Anti-atherogenic potential of jujube, saffron and barberry: anti-diabetic and antioxidant actions
Anti-Dyslipemic Effect of Suloctidil in Rhesus Monkeys Under Atherogenic Diet
Anti‐Atherogenic Effect of Stem Cell Nanovesicles Targeting Disturbed Flow Sites
Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance
Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study